Christopher W. Murray
Keine laufenden Positionen mehr
Profil
Christopher W.
Murray worked as a Principal at Protherics Plc and the University of Cambridge.
He also worked as VP-Computational Chemistry & Informatics at Astex Therapeutics Ltd.
and as a Principal at Indiana University.
Murray earned a doctorate degree from the University of Cambridge in 1989.
Ehemalige bekannte Positionen von Christopher W. Murray
| Unternehmen | Position | Ende |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Protherics Plc
 Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK. | Corporate Officer/Principal | - |
| Indiana University | Corporate Officer/Principal | - |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Christopher W. Murray
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Protherics Plc
Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK. | Health Technology |
